{"DataElement":{"publicId":"64877","version":"4","preferredName":"Melanoma Tumor Clinical N Stage","preferredDefinition":"the exent of nodal involvement of melanoma as determined prior to treatment based on evidence obtained from clinical assessment parameters (physcial examination, imaging, endoscopy, biopsy, surgical exploration, etc.). AJCC Cancer Staging Manual, 6th Ed.","longName":"MELANOM_TUMOR_C_N_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2192168","version":"1","preferredName":"Melanoma Tumor Clinical N Stage","preferredDefinition":"information related to clinical N stage of a melanoma tumor.","longName":"MELANOMA_TUMOR_C_N","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206800","version":"1","preferredName":"Melanoma Neoplasm","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes that contain melanin.  Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma.  Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi.  Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C3224:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-04EC-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8EE6B6D-5A2F-5283-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Updated to use Property based on NCIt concept","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018467","version":"2","preferredName":"Melanoma Tumor Clinical N Stage","preferredDefinition":"the clinical N (nodal) stage of a melanoma, as defined by the AJCC Cancer Staging Manual, 6th Ed.","longName":"MELANOM_TUMOR_C_N_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N0","valueDescription":"NO REGIONAL LYMPH NODE METASTASIS","ValueMeaning":{"publicId":"2559539","version":"1","preferredName":"NO REGIONAL LYMPH NODE METASTASIS","longName":"2559539","preferredDefinition":"Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer cN0 TNM Finding v6 and v7","conceptCode":"C73347","definition":"Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5A0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MAESKEB","dateModified":"2018-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04FD6579-32D6-60FD-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","deletedIndicator":"No"},{"value":"N1a","valueDescription":"Metastasis to one lymph node. Clinically occult (microscopic) metastasis","ValueMeaning":{"publicId":"2576774","version":"1","preferredName":"Metastasis to one lymph node. Clinically occult (microscopic) metastasis","longName":"2576774","preferredDefinition":"Metastasis to one lymph node. Clinically occult (microscopic) metastasis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F8F3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04FD6579-32D7-60FD-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","deletedIndicator":"No"},{"value":"N1b","valueDescription":"Metastasis to one lymph node.  Clinically apparent (macroscopic) metastasis","ValueMeaning":{"publicId":"2576775","version":"1","preferredName":"Metastasis to one lymph node.  Clinically apparent (macroscopic) metastasis","longName":"2576775","preferredDefinition":"Metastasis to one lymph node.  Clinically apparent (macroscopic) metastasis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F8F4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04FD6579-32D8-60FD-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","deletedIndicator":"No"},{"value":"N2a","valueDescription":"Metastasis to 2 or 3 regional nodes or intralymphatic regional metastasis without nodal metastases. Clinically occult (microscopic) metastasis","ValueMeaning":{"publicId":"2576778","version":"1","preferredName":"Metastasis to 2 or 3 regional nodes or intralymphatic regional metastasis without nodal metastases. Clinically occult (microscopic) metastasis","longName":"2576778","preferredDefinition":"Metastasis to 2 or 3 regional nodes or intralymphatic regional metastasis without nodal metastases. Clinically occult (microscopic) metastasis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F8F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04FD6579-32D9-60FD-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"CAMPBELB","dateModified":"2005-11-07","deletedIndicator":"No"},{"value":"N2b","valueDescription":"Metastasis to 2 or 3 regional nodes or intralymphatic regional metastasis without nodal metastases. Clinically apparent (macroscopic) metastasis","ValueMeaning":{"publicId":"2576777","version":"1","preferredName":"Metastasis to 2 or 3 regional nodes or intralymphatic regional metastasis without nodal metastases. Clinically apparent (macroscopic) metastasis","longName":"2576777","preferredDefinition":"Metastasis to 2 or 3 regional nodes or intralymphatic regional metastasis without nodal metastases. Clinically apparent (macroscopic) metastasis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F8F6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04FD6579-32DA-60FD-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","deletedIndicator":"No"},{"value":"N2c","valueDescription":"Metastasis to 2 or 3 regional nodes or intralymphatic regional metastasis without nodal metastases. Satellite or in-transit metastasis without nodal metastasis","ValueMeaning":{"publicId":"2576779","version":"1","preferredName":"Metastasis to 2 or 3 regional nodes or intralymphatic regional metastasis without nodal metastases. Satellite or in-transit metastasis without nodal metastasis","longName":"2576779","preferredDefinition":"Metastasis to 2 or 3 regional nodes or intralymphatic regional metastasis without nodal metastases. Satellite or in-transit metastasis without nodal metastasis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F8F8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04FD6579-32DB-60FD-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","deletedIndicator":"No"},{"value":"N3","valueDescription":"Metastasis in >4 regional nodes, or matted lymph nodes, or in-transit metastasis or satellite(s) with metastatic regional node(s)","ValueMeaning":{"publicId":"2576780","version":"1","preferredName":"Metastasis in >4 regional nodes, or matted lymph nodes, or in-transit metastasis or satellite(s) with metastatic regional node(s)","longName":"2576780","preferredDefinition":"Metastasis in >4 regional nodes, or matted lymph nodes, or in-transit metastasis or satellite(s) with metastatic regional node(s)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F8F9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04FD6579-32DC-60FD-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","deletedIndicator":"No"},{"value":"NX","valueDescription":"REGIONAL LYMPH NODES CANNOT BE ASSESSED","ValueMeaning":{"publicId":"2559962","version":"1","preferredName":"REGIONAL LYMPH NODES CANNOT BE ASSESSED","longName":"2559962","preferredDefinition":"Lung cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pNX TNM Finding v6 and v7","conceptCode":"C60972","definition":"Lung cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B747-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"04FD6579-32DD-60FD-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"ALAIS","dateModified":"2005-11-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 6th Ed., 2002","workflowStatus":"RELEASED","registrationStatus":"Application","id":"04FD6579-32C1-60FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"COOPERM","dateModified":"2012-11-09","changeDescription":"Updated to AJCC Cancer Staging Manual, 6th Ed.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812205","version":"1","longName":"Arizona Cancer Center","context":"NCIP"},{"publicId":"2812575","version":"1","longName":"AZCC 0210","context":"NCIP"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"MELANOM_TUMOR_C_N_ST","type":"C3D Name","context":"NCIP"},{"name":"SWOG","type":"USED_BY","context":"SWOG"},{"name":"AJCCN","type":"OID, SWOG","context":"SWOG"}],"ReferenceDocuments":[{"name":"COMMENT_487","type":"COMMENT","description":"Note: Refer to the protocol for the correct version of AJCC Staging Criteria to use for disease classification.","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"N Stage, Clinical","url":null,"context":"CTEP"},{"name":"Clinical N Stage","type":"Preferred Question Text","description":"Clinical N Stage","url":null,"context":"CTEP"},{"name":"Source","type":"DATA_ELEMENT_SOURCE","description":"AJCC Cancer Staging Manual, 6th Edition","url":null,"context":"CTEP"},{"name":"N","type":"Alternate Question Text","description":"N","url":null,"context":"SWOG"}],"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 6th Ed., 2002","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"04FD6579-32EC-60FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-07","modifiedBy":"SCOTTM","dateModified":"2013-10-10","changeDescription":"Updated to AJCC Cancer Staging Manual, 6th Ed.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}